Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068346906> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W2068346906 endingPage "225" @default.
- W2068346906 startingPage "217" @default.
- W2068346906 abstract "Hydroxymethylacylfulvene (HMAF, MGI 114) is a novel antitumor drug and a potent pro-apoptotic agent that has the potential to alkylate cellular nucleophiles. The objective of these studies was to characterize drug uptake and cellular targets for drug binding in human leukemia CEM cells. The uptake of [14C]HMAF had two components: a rapid phase (0–10 min) and a slow phase. At 10 μM drug (37°), the rapid and slower phase amounted to 0.86 and 0.13 pmol/min/106cells, respectively. HMAF uptake was inhibited 82% by low temperature (4°) at 4 hr. Cell-associated HMAF localized to nuclear (50%), cytoplasmic (37%), and membrane fractions (10%). Continued drug uptake appeared to be driven by covalent binding to cellular macromolecules. Approximately 1/4 and 2/3 of cell-associated HMAF formed covalent adducts after 10 min and 4 hr, respectively, as found by perchloric acid precipitation. Drug adducts were not readily reversible; 77% of the covalently bound radiolabel was retained by the cells 20 hr after drug treatment. Combinations of DNase, RNase, and proteinase K with perchloric acid precipitation showed that approximately 60, 30, and 10% of the covalently bound drug was associated with the protein, DNA, and RNA fractions, respectively. Incubation of 100 μM [14C]HMAF (24 hr) with purified DNA, serum albumin, thioredoxin, and thioredoxin reductase resulted in 6, 22, 14, and 11 pmol [14C]HMAF/μg DNA or protein, respectively. Results indicate that multiple targets for HMAF binding may contribute to the pro-apoptotic and antiproliferative action of the drug." @default.
- W2068346906 created "2016-06-24" @default.
- W2068346906 creator A5002106474 @default.
- W2068346906 creator A5014341044 @default.
- W2068346906 creator A5044427523 @default.
- W2068346906 creator A5055137572 @default.
- W2068346906 date "1999-07-01" @default.
- W2068346906 modified "2023-09-28" @default.
- W2068346906 title "Drug uptake and cellular targets of hydroxymethylacylfulvene (HMAF)" @default.
- W2068346906 cites W1584273408 @default.
- W2068346906 cites W1589402586 @default.
- W2068346906 cites W1937481441 @default.
- W2068346906 cites W1971316663 @default.
- W2068346906 cites W1976274817 @default.
- W2068346906 cites W1990414820 @default.
- W2068346906 cites W2009606158 @default.
- W2068346906 cites W2014836812 @default.
- W2068346906 cites W2017192757 @default.
- W2068346906 cites W2068327290 @default.
- W2068346906 cites W2072711755 @default.
- W2068346906 cites W2082359412 @default.
- W2068346906 cites W2082813030 @default.
- W2068346906 cites W2084954790 @default.
- W2068346906 cites W2092443356 @default.
- W2068346906 cites W2141802124 @default.
- W2068346906 cites W2144605551 @default.
- W2068346906 cites W2163509831 @default.
- W2068346906 cites W2236241003 @default.
- W2068346906 cites W2244063038 @default.
- W2068346906 cites W2950893218 @default.
- W2068346906 cites W4293247451 @default.
- W2068346906 doi "https://doi.org/10.1016/s0006-2952(99)00085-4" @default.
- W2068346906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10423161" @default.
- W2068346906 hasPublicationYear "1999" @default.
- W2068346906 type Work @default.
- W2068346906 sameAs 2068346906 @default.
- W2068346906 citedByCount "49" @default.
- W2068346906 countsByYear W20683469062012 @default.
- W2068346906 countsByYear W20683469062014 @default.
- W2068346906 countsByYear W20683469062015 @default.
- W2068346906 countsByYear W20683469062019 @default.
- W2068346906 countsByYear W20683469062022 @default.
- W2068346906 countsByYear W20683469062023 @default.
- W2068346906 crossrefType "journal-article" @default.
- W2068346906 hasAuthorship W2068346906A5002106474 @default.
- W2068346906 hasAuthorship W2068346906A5014341044 @default.
- W2068346906 hasAuthorship W2068346906A5044427523 @default.
- W2068346906 hasAuthorship W2068346906A5055137572 @default.
- W2068346906 hasConcept C153911025 @default.
- W2068346906 hasConcept C178790620 @default.
- W2068346906 hasConcept C180577832 @default.
- W2068346906 hasConcept C181199279 @default.
- W2068346906 hasConcept C185592680 @default.
- W2068346906 hasConcept C2777737464 @default.
- W2068346906 hasConcept C538909803 @default.
- W2068346906 hasConcept C552990157 @default.
- W2068346906 hasConcept C55493867 @default.
- W2068346906 hasConcept C86803240 @default.
- W2068346906 hasConceptScore W2068346906C153911025 @default.
- W2068346906 hasConceptScore W2068346906C178790620 @default.
- W2068346906 hasConceptScore W2068346906C180577832 @default.
- W2068346906 hasConceptScore W2068346906C181199279 @default.
- W2068346906 hasConceptScore W2068346906C185592680 @default.
- W2068346906 hasConceptScore W2068346906C2777737464 @default.
- W2068346906 hasConceptScore W2068346906C538909803 @default.
- W2068346906 hasConceptScore W2068346906C552990157 @default.
- W2068346906 hasConceptScore W2068346906C55493867 @default.
- W2068346906 hasConceptScore W2068346906C86803240 @default.
- W2068346906 hasIssue "2" @default.
- W2068346906 hasLocation W20683469061 @default.
- W2068346906 hasLocation W20683469062 @default.
- W2068346906 hasOpenAccess W2068346906 @default.
- W2068346906 hasPrimaryLocation W20683469061 @default.
- W2068346906 hasRelatedWork W1566235420 @default.
- W2068346906 hasRelatedWork W1963526513 @default.
- W2068346906 hasRelatedWork W1989001695 @default.
- W2068346906 hasRelatedWork W2012111806 @default.
- W2068346906 hasRelatedWork W2023923217 @default.
- W2068346906 hasRelatedWork W2077016287 @default.
- W2068346906 hasRelatedWork W2915648405 @default.
- W2068346906 hasRelatedWork W2996656052 @default.
- W2068346906 hasRelatedWork W4200160080 @default.
- W2068346906 hasRelatedWork W4362499781 @default.
- W2068346906 hasVolume "58" @default.
- W2068346906 isParatext "false" @default.
- W2068346906 isRetracted "false" @default.
- W2068346906 magId "2068346906" @default.
- W2068346906 workType "article" @default.